AnaptysBio Inc - Company Profile

Powered by

All the sales intelligence you need on AnaptysBio Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how AnaptysBio Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with AnaptysBio Inc.

Back to companies

AnaptysBio Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on AnaptysBio Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into AnaptysBio Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

John Orwin

Chairman Executive Board Since: 2023 Age: 64

Mr. John Orwin has been the Chairman of the company since 2023. Prior to this, he served as a member of the Board of Directors of CARGO Therapeutics Inc since August 2022 and Travere Therapeutics Inc since March 2017. Previously, he served as a Member of the Board of Directors of Seagen Inc from January 2014 until its acquisition by Pfizer Inc in December 2023 and Array BioPharma Inc from November 2012 to July 2019.

Read Hide full bio of John Orwin

Daniel Faga

Chief Executive Officer; Director; President Executive Board Since: 2023 Age: 46

Mr. Daniel Faga has been the President, Chief Executive Officer, and Director of the company since 2023. Prior to this, he served as the Chief Operating Officer at Mirati Therapeutics from 2020 to 2021. Previously, he worked as the Chief Business Officer for Spark Therapeutics Inc from 2016 to 2019. Mr. Faga also served as the Managing Director at Centerview Partners from 2009 to 2016.

Read Hide full bio of Daniel Faga

Dennis Mulroy

Chief Financial Officer Senior Management Since: 2020 Age: 71

Mr. Dennis Mulroy has been the Chief Financial Officer of the company since 2022. Prior to this, he served as the Chief Financial Officer of Taxus Cardium Pharmaceuticals Group, Molecular Imaging and SeraCare Life Sciences.

Read Hide full bio of Dennis Mulroy

Eric Loumeau

Chief Legal Officer Senior Management Since: 2023 Age: 63

Mr. Eric Loumeau has been the Chief Legal Officer of the company since 2023. Prior to this, he served as the Chief Operating Officer and General Counsel of the company. Previously, he served as the General Counsel and Chief Compliance Officer of Otonomy. Mr. Loumeau also served as the Chief Financial Officer of Rempex Pharmaceutics and General Counsel of Hollis-Eden Pharmaceuticals.

Read Hide full bio of Eric Loumeau

Paul F. Lizzul, M.D., Ph.D.

Chief Medical Officer Senior Management Since: 2020 Age: 51

Mr. Paul F. Lizzul has been the Chief Medical Officer of the company since 2020. Prior to this, he served as the Global Development Head for Inflammation at Amgen. Previously, he served as the Chief Medical Officer of Sienna Biopharmaceuticals and the Senior Medical Director of Kythera Biopharmaceuticals.

Read Hide full bio of Paul F. Lizzul, M.D., Ph.D.
Gain a 360-degree view of AnaptysBio Inc and make more informed decisions for your business Gain a 360-degree view of AnaptysBio Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer